Immix Biopharma, Inc. (IMMX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $93.80M | +607.8% |
| 2024 | $13.25M | -18.2% |
| 2023 | $16.20M | +23.1% |
| 2022 | $13.16M | -26.8% |
| 2021 | $17.99M | +480.3% |
| 2020 | -$4.73M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $93.80M | +607.8% |
| 2024 | $13.25M | -18.2% |
| 2023 | $16.20M | +23.1% |
| 2022 | $13.16M | -26.8% |
| 2021 | $17.99M | +480.3% |
| 2020 | -$4.73M | — |